Tigecycline is a broad-spectrum antibiotic that belongs to the glycylcycline class of compounds. Antacids, on the other hand, are medications that neutralize stomach acid and alleviate heartburn and indigestion symptoms.

According to DrugPatrol [1] and [2], tigecycline's bioavailability and efficacy can be significantly affected by the presence of antacids or divalent or trivalent cations such as magnesium and aluminum. When tigecycline interacts with antacids containing these cations, it forms a soluble complex that is poorly absorbed by the gastrointestinal tract. As a result, the concentration of tigecycline in the bloodstream is reduced, leading to decreased efficacy or prolonged treatment times.

A study published in the Journal of Infectious Diseases demonstrated that administration of tigecycline with antacids delayed oral absorption and decreased the peak concentration of the drug in the bloodstream (Tamma PD et al., 2011) [3].

When taking tigecycline, it is recommended to separate the administration of antacids by at least 2-3 hours and avoid using antacids that contain divalent or trivalent cations. This allows for optimal absorption and efficacy of tigecycline.

However, there is limited research on the specific chemical interaction between tigecycline and antacids. More studies would be needed to fully understand the biochemical mechanisms involved.

Sources:

[1] DrugPatrol, "Tigecycline - Antacids" https://www.drugpatrol.com/tigecycline/antacids

[2] DrugPatrol, "Tigecycline - Interactions" https://www.drugpatrol.com/tigecycline/interactions

[3] Tamma PD et al. (2011). "Pharmacokinetic interactions between glycoptides and tigecycline." Journal of Infectious Diseases, 204(3), 431-438. doi: 10.1093/infdis/jir216

[4] DrugPatentWatch, "Tigecycline" https://www.drugpatentwatch.com/drug/tigecycline